Paper - WANFANG MED ONLINE

You Position: Home > Paper

Role of Ring Finger Protein 213 in Moyamoya Disease

( views:42, downloads:33 )

Author:: No author available

Journal Title:: Chinese Medical Journal

Issue:: 20

DOI:: 10.4103/0366-6999.191824

Key Word:: Moyamoya Disease;Research Progress;Ring Finger Protein 213;Variant

Abstract： Objective:The aim of this study was to help people comprehensively understand the research advances related to ring finger protein 213 (RNF213) in moyamoya disease (MMD) and to understand the disease at the molecular level to provide a new perspective of the diagnosis of the disease.Data Sources:This review was based on data in articles published between 2005 and 2015 that were retrieved from the PubMed database.The search terms included RNF213,MMD,intracranial major artery stenosis/occlusion (ICASO),genotype,phenotype,mutant and variants,and the combinations of these terms.Study Selection:Articles related to MMD and RNF213 were selected for review,and we also reviewed publications related to ICASO.Results:RNF213 is not only associated with MMD but also associated with intracranial major artery stenosis.In addition,RNF213 variants exhibit apparent ethnic diversity;specifically,the c.14576G＞A variant is mainly detected in Korean,Chinese,and Japanese populations,particularly the latter population.The genotypes of RNF213 correlate with the phenotypes of MMD;for example,the homozygous c.14576G＞A variant is associated with early-onset,severe symptoms,and an unfavorable prognosis.Furthermore,the RNF213 c.14576G＞A variant should be considered during the diagnosis of MMD because no patients with quasi-MMD have been reported to carry the RNF213 c.14576G＞A variant whereas 66 of 78 patients with definite MMD have been found to carry this variant.Conclusions:The growing literature demonstrates that MMD is primarily caused by the synergy of genetic and environmental factors,and unknown genetic modifiers might play roles in the etiology of MMD.Further research should be conducted to clarify the pathogenic mechanism of MMD.

Reference

[1]Kanoke, Atsushi,Fujimura, Miki,Niizuma, Kuniyasu,etc.Temporal profile of the vascular anatomy evaluated by 9.4-tesla magnetic resonance angiography and histological analysis in mice with the R4859K mutation of RNF213, the susceptibility gene for moyamoya disease[J].2015,1624.
[2]Hitomi,T.,Okuda,H.,Nanayakkara,S.,etc.P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure[J].2013,18(2).
[3]T, Tanigawara,H, Yamada,N, Sakai,etc.Studies on cytomegalovirus and Epstein-Barr virus infection in moyamoya disease.[J].1997,99.
[4]D H, Han,D H, Nam,C W, Oh.Moyamoya disease in adults: characteristics of clinical presentation and outcome after encephalo-duro-arterio-synangiosis.[J].1997,99 Suppl 2.
[5]Liu,W.,Takashima,S.,Hitomi,T.,etc.Ablation of Rnf213 retards progression of diabetes in the Akita mouse[J].2013,432(3).
[6]Zhiyuan Wu,Hanqiang Jiang,Lei Zhang,etc.Molecular Analysis of RNF213 Gene for Moyamoya Disease in the Chinese Han Population.[J].2012,7(10).
[7]Baba T,Houkin K,Kuroda S.Novel epidemiological features of moyamoya disease.[J].2008,79(8).
[8]Ahn, Jae Sung,Ko, Tae-Sung,Yoo, Han-Wook,etc.Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease[J].2016,124(5).
[9]Shunsaku Takayanagi,Hideaki Imai,Hirofumi Nakatomi,etc.Identification of a Genetic Variant Common to Moyamoya Disease and Intracranial Major Artery Stenosis/Occlusion[J].2012,43(12).
[10]Ken, Uchino,S Claiborne, Johnston,Kyra J, Becker,etc.Moyamoya disease in Washington State and California.[J].2005,65.
[11]Kazuhiro, Ohkubo,Yasunari, Sakai,Hirosuke, Inoue,etc.Moyamoya disease susceptibility gene RNF213 links inflammatory and angiogenic signals in endothelial cells.[J].2015,5.
[12]R Michael, Scott,Edward R, Smith.Moyamoya disease and moyamoya syndrome.[J].2009,360(12).
[13]Hitomi,T.,Habu,T.,Kobayashi,H.,etc.Downregulation of Securin by the variant RNF213 R4810K(rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients[J].2013,438(1).
[14]Kuriyama S,Kusaka Y,Fujimura M,etc.Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey.[J].2008,39(1).
[15]S Miyatake,N Miyake,H Touho,etc.Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease.[J].2012,78(11).
[16]Ito, Akira,Fujimura, Miki,Niizuma, Kuniyasu,etc.Enhanced post-ischemic angiogenesis in mice lacking RNF213; a susceptibility gene for moyamoya disease[J].2015,1594.
[17]Wanyang Liu,Morito, Daisuke,Takashima, Seiji,etc.Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development.[J].2011,6(7).
[18]Oka A,Koeda T,Ueno M,etc.Unilateral occlusion of the middle cerebral artery after varicella-zoster virus infection.[J].2002,24(2).
[19]Fukushima, Hiroyuki,Takenouchi, Toshiki,Kosaki, Kenjiro.Homozygosity for Moyamoya Disease Risk Allele Leads to Moyamoya Disease with Extracranial Systemic and Pulmonary Vasculopathy[J].2016,170A(9).
[20]Sato-Maeda, Mika,Fujimura, Miki,Kanoke, Atsushi,etc.Transient middle cerebral artery occlusion in mice induces neuronal expression of RNF213, a susceptibility gene for moyamoya disease[J].2016,1630.
[21]M, Fukui,S, Kono,K, Sueishi,etc.Moyamoya disease.[J].2000,20 Suppl.
[22]Morita,S.,Ohba,C.,Miyatake,S.,etc.Sibling cases of moyamoya disease having homozygous and heterozygous c.14576G>A variant in RNF213 showed varying clinical course and severity[J].2012,57(12).
[23]Hitomi,T.,Habu,T.,Kobayashi,H.,etc.The moyamoya disease susceptibility variant RNF213 R4810K (rs112735431) induces genomic instability by mitotic abnormality[J].2013,439(4).
[24]Kamada F,Aoki Y,Narisawa A,etc.A genome-wide association study identifies RNF213 as the first Moyamoya disease gene.[J].2011,56(1).
[25]Anand, Veeravagu,Raphael, Guzman,Chirag G, Patil,etc.Moyamoya disease in pediatric patients: outcomes of neurosurgical interventions.[J].2008,24.
[26]Hatasu, Kobayashi,Yoshiko, Matsuda,Toshiaki, Hitomi,etc.Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo.[J].2015,4(7).
[27]Daisuke, Morito,Kouki, Nishikawa,Jun, Hoseki,etc.Moyamoya disease-associated protein mysterin/RNF213 is a novel AAA+ ATPase, which dynamically changes its oligomeric state.[J].2014,4.
[28]Suzuki,N.,Izawa,Y.,Hoshino,H..Epidemiological Features of Moyamoya Disease in Japan[J].2012,52(5).
[29]Hayashi,K.,Horie,N.,Izumo,T.,etc.Nationwide survey on quasi-moyamoya disease in Japan[J].2014,156(5).
[30]Bayram, Ayse Kacar,Ito, Masaki,Uchino, Haruto,etc.Familial moyamoya disease in two Turkish siblings with same polymorphism in RNF213 gene but different clinical features[J].2016,32(3).
[31]Shinya Sonobe,Mifei Fujimura,Kuniyasu Niizuma,etc.Temporal profile of the vascular anatomy evaluated by 9.4-T magnetic resonance angiography and histopathological analysis in mice lacking RNF213: A susceptibility gene for moyamoya disease[J].2014,1552.
[32]Alana C Cecchi,Dongchuan Guo,Zhao Ren,etc.RNF213 rare variants in an ethnically diverse population with Moyamoya disease.[J].2014,45(11).
[33]Wanyang Liu,Yohei Mineharu,Yasushi Takagi,etc.Rapid progression of unilateral moyamoya disease in a patient with a family history and an RNF213 risk variant.[J].2013,36(2).
[34]Yosuke, Moteki,Hideaki, Onda,Hidetoshi, Kasuya,etc.Systematic Validation of RNF213 Coding Variants in Japanese Patients With Moyamoya Disease.[J].2015,4(5).